KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Jazz Pharmaceuticals (JAZZ) Long-Term Debt Issuances (2016 - 2021)

Jazz Pharmaceuticals (JAZZ) has 7 years of Long-Term Debt Issuances data on record, last reported at $981.4 million in Q4 2020.

  • For Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $981.4 million; the TTM value through Sep 2022 reached $981.4 million, changed N/A, while the annual FY2024 figure was $980.8 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $981.4 million in Q4 2020 per JAZZ's latest filing, up from -$981.4 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $994.8 million in Q3 2016 and bottomed at -$981.4 million in Q3 2020.
  • Average Long-Term Debt Issuances over 3 years is $198.9 million, with a median of -$91000.0 recorded in 2017.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 48791.97% in 2016, then skyrocketed 30.0% in 2017.
  • A 3-year view of Long-Term Debt Issuances shows it stood at -$130000.0 in 2016, then rose by 30.0% to -$91000.0 in 2017, then surged by 1078540.66% to $981.4 million in 2020.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $981.4 million in Q4 2020, -$981.4 million in Q3 2020, and -$91000.0 in Q4 2017.